Vicore Pharma Holding AB (publ) (STO: VICO)

Vicore Pharma Holding AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,825	1,584	1,465	999	1,903	738
Market Cap Growth	-52.87%	8.13%	46.67%	-47.51%	158.03%	39.86%
Enterprise Value	1,445	1,033	1,295	552	1,542	565
Last Close Price	7.78	13.80	17.42	13.54	30.65	14.30
PS Ratio	8.34	-	-	-	-	-
PB Ratio	2.30	3.48	5.07	2.61	5.37	2.29
P/TBV Ratio	2.13	3.50	6.63	3.16	6.71	2.91
EV/Sales Ratio	13.86	-	-	-	-	-
Debt / Equity Ratio	-	-	0.00	0.00	0.00	0.00
Asset Turnover	0.20	-	-	-	-	-
Quick Ratio	13.42	11.86	5.69	5.67	6.81	15.69
Current Ratio	14.27	12.10	5.81	5.75	6.82	15.72
Return on Equity (ROE)	-41.61%	-83.53%	-85.79%	-80.37%	-43.44%	-30.67%
Return on Assets (ROA)	-26.70%	-47.99%	-45.54%	-42.76%	-27.92%	-18.27%
Return on Capital (ROIC)	-28.82%	-53.87%	-53.41%	-49.68%	-30.86%	-19.33%
Earnings Yield	-22.59%	-19.63%	-19.69%	-29.68%	-7.72%	-12.62%
FCF Yield	-22.50%	-15.75%	-20.47%	-26.55%	-6.30%	-11.82%
Buyback Yield / Dilution	-28.57%	-33.71%	-3.64%	-28.44%	-26.04%	-88.10%
Total Shareholder Return	-28.57%	-33.71%	-3.64%	-28.44%	-26.04%	-88.10%

Source: S&P Capital IQ. Standard template. Financial Sources.